Patent Term Extension Application for LIFYORLI® (relacorilant), Patent No. 10,456,392 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-E-8230

Patent Term Extension Application for LIFYORLI® (relacorilant), Patent No. 10,456,392

Documents

Comments

Description

OPEN

Comment Period OpensJul 30, 2026

Type	Title	Posted	Comments	Status
Other	Patent Term Extension Application from Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (on behalf of Corcept Therapeutics Incorporated)	Jul 30, 2026	--

CDER

Patent Term Extension Application for LIFYORLI®

Corcept Therapeutics Incorporated

Mintz, Levin, Cohn, Ferris,

Glovsky and Popeo, P.C.

(relacorilant)

Patent No. 10,456,392

OPEN